New York, NY -- (SBWIRE) -- 09/28/2013 -- StockMarketIntel.com issues a special report on the following stocks: IAMGOLD Corp (USA)(NYSE:IAG), Geron Corporation(NASDAQ:GERN), RadioShack Corporation (NYSE:RSH), Optimer Pharmaceuticals, Inc.(NASDAQ:OPTR)
IAMGOLD Corp (USA)(NYSE:IAG) recently declined -1.24%, while trading on 6.29 million shares at the price of $4.77. If we look at its trading history of the past 52 weeks, the share price suffered a low of $3.81 and was moved to its maximum level of $16.88.The stock changed hands in a range of $4.76 to $4.97, bringing its market capitalization at about $1.80 billion.
Has IAG Found The Bottom and Ready To Move Up? Find Out Here
Geron Corporation (NASDAQ:GERN) recently added +10.45% and was moving within a range of $0.91-$3.95, its current trading price is $3.70. The stock is moving up till now with a total volume of 6.10million shares, versus an average volume of 1.44 million shares. The share price hit its 52-week low of $0.91 and $3.95 was the best price. Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Where GERN is Headed Exactly? Find out in This Trend Analysis Reports
RadioShack Corporation (NYSE:RSH) declined -11.11% recently, in the current trading session, at $3.44 with a total volume of 5.85 million shares. The stock, on average, trades on a volume of 3.02 million shares. It floated in a range of $3.40 to $3.85 during the recent trading session, with a beta value of 1.55. Its market capitalization now moved to about $342.98 million. In the past 52 weeks, the share price has not declined below $1.90 or above $4.36. RadioShack Corporation engages in the retail sale of consumer electronics goods and services through its RadioShack store chain.
Should RSH a Buy or Sell Now? Find Out Here
Optimer Pharmaceuticals, Inc.(NASDAQ:OPTR) declined -0.32% recently, while trading on 5.81 million shares at the price of $12.63. If we look at its trading history of the past 52 weeks, the share price suffered a low of $8.64 and was moved to its maximum level of $16.80.The stock changed hands in a range of $12.58 to $12.70, bringing its market capitalization at about $617.60 million. Optimer Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products in the United States and Canada..
Can OPTR Show a Strong Recovery? Find out in This Research Report
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)